Physician profile
Abeel Mangi
NPI 1811035256
$14,854.97
in general payments reported to CMS, 2019-2025
8 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,481 · 2020: $20.19 · 2021: $59.28 · 2023: $132 · 2024: $1,271 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Travel and Lodging: $1,857 · Food and Beverage: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,000.00 |
| Travel and Lodging | $1,857.23 |
| Food and Beverage | $1,437.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,661.25 | 2025 | |
| Boston Scientific Corporation | $1,370.42 | 2019 | |
| Edwards Lifesciences Corporation | $1,087.15 | 2023-2024 | Inspiris Resilia Aortic Valve |
| Abiomed | $319.03 | 2024-2025 | Impella |
| Atricure, INC. | $111.78 | 2024-2025 | Atriclip Laa Exclusion System |
| Medtronic Vascular, INC. | $110.39 | 2019 | |
| Abbott Laboratories | $109.90 | 2020-2024 | Epic |
| Medtronic, INC. | $85.05 | 2023-2024 | Corevalve Evolut R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abeel Mangi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.